Axel Linke
Latest contributions
Management of challenging TAVI device delivery
22 May 2025 – From EuroPCR 2025
Explore innovative solutions for managing challenging TAVI device delivery. This session presents cases involving kinked and stuck Navitor valves, the use of snare devices for retrieval, balloon-expandable TAVI in severe bicuspid aortic stenosis, and alternative access routes such as transaortic access after failed transfemoral valve-in-valve procedures.
TAVI in bicuspid aortic valve disease
22 May 2025 – From EuroPCR 2025
Explore the unique challenges of TAVI in bicuspid aortic valve disease with a focus on long-term outcomes, residual gradients, prosthesis-patient mismatch, and anatomical subtype comparisons. This session draws on international registry data to inform clinical decision-making and optimize procedural strategies in this complex patient population.
Align for the future with case-based discussions on next generation balloon expandable transcatheter heart valve technology
16 May 2024 – From EuroPCR 2024
Join this EuroPCR 2024 session to delve into the cutting-edge innovations and techniques shaping transcatheter heart valve interventions. Witness firsthand the versatility of the Myval Octacor THV platform, navigating through challenging scenarios with ease, explore the significance of lifetime patient management in TAVI, unveiling the novel...
LANDMARK RCT - Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
15 May 2024 – From EuroPCR 2024
This session provides an overview of the early outcomes of the LANDMARK trial, a randomized non-inferiority trial comparing TAVI devices. It examines baseline characteristics, the significance of intermediate sizes according to MSCT recommendations, real-world representative cases from the LANDMARK RCT, insights from quantitative aortography and echocardiography...
Pushing the limits of transcatheter mitral valve interventions
15 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 Clinical Case submissions showcasing the latest advancements and challenges in transcatheter mitral valve interventions. Experts will present and discuss complex cases involving severely calcified mitral valves, mitral valve-in-ring implantations, and the management of mitral regurgitation associated with hypertrophic obstructive cardiomyopathy....
Addressing remaining issues after TAVI: what to expect from the new generation?
21 Nov 2023 – From PCR London Valves 2023
Consult this session if you want to discuss the challenges of TAVI for lower-risk patients, and to capture the features of new TAVI devices.
Hot TAVI topics - Cerebral embolic protection
27 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the latest data concerning cerebral embolic protection (CEP) in TAVI, to find out about currently available and emerging embolic protection devices and to get a better understanding of variations in head and neck vessel anatomy and tips and tricks...
A team approach to the management of tricuspid regurgitation
Consult this session to learn all about tricuspid valve disease: anatomy, imaging, guideline-directed treatment, and discover new transcatheter treatment options for tricuspid regurgitation, as well as the specific advantages of the Edwards Cardioband tricuspid valve reconstruction system for your patients.
Tricuspid Regurgitation (TR) management with the Cardioband Tricuspid System
Georg Nickenig and Axel Linke from Germany describe how the Cardioband can be used to treat tricuspid regurgitation by addressing annular dilation. Watch this video to find out more about how the device is used to reduce the size of the annulus, the most suitable patients...
Long-term clinical outcomes after SAVR and TAVI
19 Nov 2019 – From PCR London Valves 2019
Consult this session to learn all about the long-term clinical outcomes after SAVR and TAVI, thanks to a variety of studies and registries: BIVOLUT-X, STS/ACC TVT, and more!
Treatment of aortic stenosis for today - Important considerations for the future
Consult this session to learn more about some important considerations when selecting your TAVI device, how innovations drive improvement in procedural and clinical outcomes, and discover various procedural techniques using the latest generation TAVI system, such as Portico IDE FlexNav, NAVITOR next-gen self-expanding valve, and more!
Heart Team 2.0 in action: how to manage complex TAVI procedures
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn how to plan a successful TAVI procedure for your patients with challenging anatomy and high-risk clinical characteristics, such as: with a bicuspid aortic valve and associated aortopathy, with severe LVOT calcification, with a high risk of left main coronary occlusion, and more!
Case-based learning for the Heart Valve Team: bioprosthetic valve thrombosis
18 Nov 2019 – From PCR London Valves 2019
Consult this session on bioprosthetic valve thrombosis to learn more about its detection and management, with a focus on the key role of imaging in the follow-up of patients, and discover how to identify patients at high risk of thrombosis or bleeding and their optimal management.
TAVI and stroke prevention
24 May 2019 – From EuroPCR 2019
Consult this session to learn all about how to prevent stroke during TAVI, especially in patients at high risk for cerebral embolism or with atrial fibrillation, through cerebral protection devices, anticoagulation, LAA closure, and more!
Complications of TAVI - Part 1
23 May 2019 – From EuroPCR 2019
Consult this session to learn how to efficiently manage TAVI complications, thanks to a selection of compelling clinical cases: reposition of trancatheter bioprosthesis Evolut R for delayed retrograde migration one week after implantation, left ventricular outflow tract - Right atrial defect after TAVI, and more!
Hotline: new developments in TAVI
22 May 2019 – From EuroPCR 2019
Consult this session to learn all about the latest developments in TAVI: discover new studies' results and novel transcatheter heart valves' clinical outcomes.
